Patent · US Active

Inhibtors of RAF kinases

US11746095B2 · kind B2 · utility

0Cited by
5References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 6, 2022
Grant dateSep 5, 2023
Priority date—
Expiry dateMay 6, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D405/12
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Provided herein are inhibitors of receptor tyrosine kinase effector, RAF, pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.